> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Glaxo Gains Rx-to-OTC Switch for Flonase Sensimist
- URL: https://www.fdaweb.com/glaxo-gains-rx-to-otc-switch-for-flonase-sensimist/
- Published: 2016-08-03T12:00:00.000Z
- Updated: 2026-09-14T21:20:45.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5136394

FDA has approved a GSK Consumer Healthcare NDA for Flonase Sensimist Allergy Relief (fluticasone furoate, 27.5 mcg spray) as an over-the-counter treatment for symptoms associated with seasonal and perennial allergies. Previously, the product was approved for prescription-only use. Flonase Sensimist provides non-drowsy, 24-hour relief of both nose- and eye-related allergy symptoms like itchy, watery eyes, nasal congestion, runny nose, itchy nose and sneezing, the company says.